Analyst Research Report Snapshot


ALK-Abello AS




MarketLine (a Datamonitor Company)


13 Jan 2015





Companies referenced:

Available for Immediate Download

ALK-Abello (or ‘the group’) is a Denmark-based pharmaceutical group engaged in the development and marketing of allergy treatment products. The group operates in Europe, the US, Canada, China and other parts of the world. It is headquartered in Horsholm, Denmark, and employed 1,855 people as on December 31, 2012. The group recorded revenues of DKK2,345 million ($405 million*) during the financial year ended December 2012 (FY2012), a decrease of 0.1% compared with FY2011. The operating profit of the group was DKK118 million ($20.4 million*) during FY2012, a decrease of 60.5% compared with FY2011. The net profit was DKK209 million ($36.1 million*) in FY2012, an increase of 4.5% over FY2011. *Calculated using a constant conversion rate of DKK1 = $0.1727 for the financial year ended December 31, 2012.

Why buy analyst research?

  • Institutional quality research
  • Available for Immediate Download
  • Detailed company or industry insight
  • Print or save
  • 24 hour customer support
Return to previous page without adding this item to your cart.
Email Customer Support.

About Analyst Research

Analyst research reports are available for immediate download after purchase. You will have unlimited access to the report for 24 hours after purchase, to download, print or save it as many times as you wish. Analyst Research provided by Reuters does not constitute investment advice, and is not endorsed by Reuters Research. This information is protected by copyright and intellectual property laws. More information on Analyst Research.